Icon Plc
WHO'M
ai
Digital Profiler. Simply click the AI button
FIGI: BBG000CTSZQ6
ICLR
Icon Plc
GICS: -
·
Sector: Healthcare
·
Sub-Sector: Diagnostics & Research
NAME
Icon Plc
ISIN
IE0005711209
TICKER
ICLR
MIC
XNAS
REUTERS
ICLR.OQ
BLOOMBERG
ICLR US
Financial Intelligence
FOR INVESTORS
FOR TRADERS
Securities Trading
Warrants
The X-News Explorer is the ultimate source of information for investors with an affinity for the stock market who want to get a quick and convenient overview of the current news situation of a listed company. Various newswire services are available to you here. If a news alert is displayed, you will find company news that may be of interest to you. This service is provided by BusinessWire.
Tue, 14.01.2025
Icon Plc
IE0005711209
ICON plc, (NASDAQ: ICLR), a world-leading clinical research organization powered by healthcare intelligence, today announced its financial guidance for the year ending December 31, 2025. For the full year 2025, revenue is expected to be in the range of $8,050 - $8,650 million, representing growth of approximately 1% at the midpoint and adjusted ea...
Icon Plc
Wed, 08.01.2025
Icon Plc
IE0005711209
ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today released the findings of a survey of over 120 biotech and pharma professionals developing treatments for neurodegenerative disorders. The findings indicate that, despite recent successes in developing disease modifying treatments for A...
Icon Plc
Tue, 07.01.2025
Icon Plc
IE0005711209
ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, today announced that Dr. Steve Cutler, CEO of ICON plc, will present at the 43rd Annual J.P. Morgan Healthcare Conference on Tuesday, January 14, 2025 at 3.45pm PST.
Any changes to this event and links to the live webcast will be posted on the In...
Icon Plc
Mon, 23.12.2024
Icon Plc
IE0005711209
ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, has been honoured with numerous awards in the second half of 2024.
On TIME Magazine’s 2024 list of World’s Best Companies ICON was ranked as the highest clinical research organisation out of 1,000 companies for the second year in a row, and in it...
Icon Plc
Wed, 18.12.2024
Icon Plc
IE0005711209
ICON plc (NASDAQ: ICLR), a world-leading healthcare intelligence and clinical research organisation, today announced the appointment of Barry Balfe as Chief Operating Officer (COO).
Barry is a long-tenured ICON employee with over 20 years of service and brings extensive leadership experience and capability to the role of COO. He has held a numbe...
Icon Plc
Thu, 05.12.2024
Icon Plc
IE0005711209
ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today announced results from a recent global survey of 101 biotech and pharma professionals across Europe and North America to understand the trajectory of AI and digital innovation adoption within clinical research.
Respondents revealed t...
Icon Plc
Wed, 27.11.2024
Icon Plc
IE0005711209
Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, continues its investigation on behalf of ICON Public Limited Company (“Icon” or the “Company”) (NASDAQ: ICLR) investors concerning the Company’s possible violations of the federal securities laws.
If you suffered a loss on your Icon investments or would like...
Icon Plc
Tue, 26.11.2024
Icon Plc
IE0005711209
Law Offices of Howard G. Smith continues its investigation on behalf of ICON Public Limited Company (“Icon” or the “Company”) (NASDAQ: ICLR) investors concerning the Company’s possible violations of federal securities laws.
On October 23, 2024, Icon released its third quarter 2024 financial results, missing consensus estimates “due to specific c...
Icon Plc
Mon, 25.11.2024
Icon Plc
IE0005711209
The Law Offices of Frank R. Cruz continues its investigation of ICON Public Limited Company (“Icon” or the “Company”) (NASDAQ: ICLR) on behalf of investors concerning the Company’s possible violations of federal securities laws.
If you are a shareholder who suffered a loss, click here to participate.
On October 23, 2024, Icon released its thir...
Icon Plc
Fri, 15.11.2024
Icon Plc
IE0005711209
Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of ICON Public Limited Company (“Icon” or the “Company”) (NASDAQ: ICLR) investors concerning the Company’s possible violations of the federal securities laws.
If you suffered a loss on your Ico...
Icon Plc
Information on product placements
SMART * AD
P R O D U C T S U G G E S T I O N S
